|
1
|
American Cancer Society. Global Cancer
Facts and Figures. 2nd Edition. http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-027766.pdf.
American Cancer Society; Atlanta, GA, USA: 2011
|
|
2
|
Almuhaideb A, Papathanasiou N and Bomanji
J: 18F-FDG PET/CT imaging in oncology. Ann Saudi Med.
31:3–13. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Baum RP, Swietaszczyk C and Prasad V:
FDG-PET/CT in lung cancer: an update. Front Radiat Ther Oncol.
42:15–45. 2010. View Article : Google Scholar
|
|
4
|
Schillaci O, Travascio L, Bolacchi F,
Calabria F, Bruni C, Cicciò C, Guazzaroni M, Orlacchio A and
Simonetti G: Accuracy of early and delayed FDG PET-CT and of
contrast-enhanced CT in the evaluation of lung nodules: a
preliminary study on 30 patients. Radiol Med. 114:890–906. 2009.(In
English and Italian). View Article : Google Scholar : PubMed/NCBI
|
|
5
|
DeGrado TR, Coleman RE, Wang S, Baldwin
SW, Orr MD, Robertson CN, Polascik TJ and Price DT: Synthesis and
evaluation of 18F-labeled choline as an oncologic tracer
for positron emission tomography: initial findings in prostate
cancer. Cancer Res. 61:110–117. 2001.PubMed/NCBI
|
|
6
|
Nanni C, Rubello D and Fanti S: Could
choline PET play a role in malignancies other than prostate cancer?
Eur J Nucl Med Mol Imaging. 35:216–218. 2008. View Article : Google Scholar
|
|
7
|
Tian M, Zhang H, Oriuchi N, Higuchi T and
Endo K: Comparison of 11C-choline PET and FDG PET for
the differential diagnosis of malignant tumors. Eur J Nucl Med Mol
Imaging. 31:1064–1072. 2004.PubMed/NCBI
|
|
8
|
Picchio M, Giovannini E, Crivellaro C,
Gianolli L, di Muzio N and Messa C: Clinical evidence on PET/CT for
radiation therapy planning in prostate cancer. Radiother Oncol.
96:347–350. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Roivainen A, Forsback S, Grönroos T,
Lehikoinen P, Kähkönen M, Sutinen E and Minn H: Blood metabolism of
(methyl-11C)choline; implications for in vivo imaging
with positron emission tomography. Eur J Nucl Med. 27:25–32. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hara T: 11C-choline and
2-deoxy-2-(18F)fluoro-D-glucose in tumor imaging with
positron emission tomography. Mol Imaging Biol. 4:267–273. 2002.
View Article : Google Scholar
|
|
11
|
Yoshimoto M, Waki A, Obata A, Furukawa T,
Yonekura Y and Fujibayashi Y: Radiolabeled choline as a
proliferation marker: comparison with radiolabeled acetate. Nucl
Med Biol. 31:859–865. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Song P, Sekhon HS, Jia Y, Keller JA,
Blusztajn JK, Mark GP and Spindel ER: Acetylcholine is synthesized
by and acts as an autocrine growth factor for small cell lung
carcinoma. Cancer Res. 63:214–221. 2003.PubMed/NCBI
|
|
13
|
Song P, Sekhon HS, Proskocil B, Blusztajn
JK, Mark GP and Spindel ER: Synthesis of acetylcholine by lung
cancer. Life Sci. 72:2159–2168. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pascali C, Bogni A, Itawa R, Cambie M and
Bombardieri E: [11C]Methylation on a C18
Sep-Pak cartridge: a convenient way to produce
[N-methyl-11C]choline. J Labelled Comp Rad. 43:195–203.
2000. View Article : Google Scholar
|
|
15
|
Pieterman RM, Que TH, Elsinga PH, Pruim J,
van Putten JW, Willemsen AT, Vaalburg W and Groen HJ: Comparison of
(11) C-choline and (18)F-FDG PET in primary
diagnosis and staging of patients with thoracic cancer. J Nucl Med.
43:167–172. 2002.PubMed/NCBI
|
|
16
|
Wang T, Sun YE, Yao SL, Yu CH, Yin DY and
Tian JH: Value of carbon-11 choline positron emission tomography in
patients with pulmonary abnormalities. Zhonghua Wai Ke Za Zhi.
44:405–408. 2006.(In Chinese). PubMed/NCBI
|
|
17
|
Khan N, Oriuchi N, Zhang H, Higuchi T,
Tian M, Inoue T, Sato N and Endo K: A comparative study of
11C-choline PET and (18F)fluorodeoxyglucose
PET in the evaluation of lung cancer. Nucl Med Commun. 24:359–366.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Maus AD, Pereira EF, Karachunski PI,
Horton RM, Navaneetham D, Macklin K, Cortes WS, Albuquerque EX and
Conti-Fine BM: Human and rodent bronchial epithelial cells express
functional nicotinic acetylcholine receptors. Mol Pharmacol.
54:779–788. 1998.PubMed/NCBI
|
|
19
|
Lam DC, Girard L, Ramirez R, Chau WS, Suen
WS, Sheridan S, Tin VP, Chung LP, Wong MP, Shay JW, Gazdar AF, Lam
WK and Minna JD: Expression of nicotinic acetylcholine receptor
subunit genes in non-small-cell lung cancer reveals differences
between smokers and nonsmokers. Cancer Res. 67:4638–4647. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zia S, Ndoye A, Nguyen VT and Grando SA:
Nicotine enhances expression of the alpha 3, alpha 4, alpha 5, and
alpha 7 nicotinic receptors modulating calcium metabolism and
regulating adhesion and motility of respiratory epithelial cells.
Res Commun Mol Pathol Pharmacol. 97:243–262. 1997.PubMed/NCBI
|
|
21
|
Zhang H, Tian M, Oriuchi N, Higuchi T,
Watanabe H, Aoki J, Tanada S and Endo K: 11C-choline PET
for the detection of bone and soft tissue tumours in comparison
with FDG PET. Nucl Med Commun. 24:273–279. 2003. View Article : Google Scholar : PubMed/NCBI
|
